國立虎尾科技大學 |

Tumor Organoids

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Tumor Organoids/ edited by Shay Soker, Aleksander Skardal.
other author:	Soker, Shay.
Description:	XVI, 213 p. 52 illus., 50 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Cancer research. -
Online resource:	https://doi.org/10.1007/978-3-319-60511-1
ISBN:	9783319605111

Tumor Organoids
Tumor Organoids[electronic resource] /edited by Shay Soker, Aleksander Skardal. - 1st ed. 2018. - XVI, 213 p. 52 illus., 50 illus. in color.online resource. - Cancer Drug Discovery and Development,2196-9906. - Cancer Drug Discovery and Development,.

Techniques to Produce and Culture Lung Tumor Organoids -- Tissue Organoids: Liver -- Mammary Gland Organoids -- Biofabrication Technologies for Developing In Vitro Tumor Models -- Three Dimensional In Vitro Tumor Platforms for Cancer Discovery -- Tissue-engineered models for studies of bone metastasis -- Building Better Tumor Models: Organoid Systems to Investigate Angiogenesis -- Microfluidics in cell and tissue studies -- Stiffness-tuned matrices for tumor cell studies -- Mathematical modeling of tumor organoids: toward personalized medicine.

Cancer cell biology research in general, and anti-cancer drug development specifically, still relies on standard cell culture techniques that place the cells in an unnatural environment. As a consequence, growing tumor cells in plastic dishes places a selective pressure that substantially alters their original molecular and phenotypic properties.The emerging field of regenerative medicine has developed bioengineered tissue platforms that can better mimic the structure and cellular heterogeneity of in vivo tissue, and are suitable for tumor bioengineering research. Microengineering technologies have resulted in advanced methods for creating and culturing 3-D human tissue. By encapsulating the respective cell type or combining several cell types to form tissues, these model organs can be viable for longer periods of time and are cultured to develop functional properties similar to native tissues. This approach recapitulates the dynamic role of cell–cell, cell–ECM, and mechanical interactions inside the tumor. Further incorporation of cells representative of the tumor stroma, such as endothelial cells (EC) and tumor fibroblasts, can mimic the in vivo tumor microenvironment. Collectively, bioengineered tumors create an important resource for the in vitro study of tumor growth in 3D including tumor biomechanics and the effects of anti-cancer drugs on 3D tumor tissue. These technologies have the potential to overcome current limitations to genetic and histological tumor classification and development of personalized therapies.

ISBN: 9783319605111

Standard No.: 10.1007/978-3-319-60511-1doiSubjects--Topical Terms:

1253664
Cancer research.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Tumor Organoids
LDR:03478nam a22004095i 4500 001 996617
003 DE-He213
005 20200701175602.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319605111 $9 978-3-319-60511-1
024 7 $a 10.1007/978-3-319-60511-1 $2 doi
035 $a 978-3-319-60511-1
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
245 1 0 $a Tumor Organoids $h [electronic resource] / $c edited by Shay Soker, Aleksander Skardal.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2018.
300 $a XVI, 213 p. 52 illus., 50 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Cancer Drug Discovery and Development, $x 2196-9906
505 0 $a Techniques to Produce and Culture Lung Tumor Organoids -- Tissue Organoids: Liver -- Mammary Gland Organoids -- Biofabrication Technologies for Developing In Vitro Tumor Models -- Three Dimensional In Vitro Tumor Platforms for Cancer Discovery -- Tissue-engineered models for studies of bone metastasis -- Building Better Tumor Models: Organoid Systems to Investigate Angiogenesis -- Microfluidics in cell and tissue studies -- Stiffness-tuned matrices for tumor cell studies -- Mathematical modeling of tumor organoids: toward personalized medicine.
520 $a Cancer cell biology research in general, and anti-cancer drug development specifically, still relies on standard cell culture techniques that place the cells in an unnatural environment. As a consequence, growing tumor cells in plastic dishes places a selective pressure that substantially alters their original molecular and phenotypic properties.The emerging field of regenerative medicine has developed bioengineered tissue platforms that can better mimic the structure and cellular heterogeneity of in vivo tissue, and are suitable for tumor bioengineering research. Microengineering technologies have resulted in advanced methods for creating and culturing 3-D human tissue. By encapsulating the respective cell type or combining several cell types to form tissues, these model organs can be viable for longer periods of time and are cultured to develop functional properties similar to native tissues. This approach recapitulates the dynamic role of cell–cell, cell–ECM, and mechanical interactions inside the tumor. Further incorporation of cells representative of the tumor stroma, such as endothelial cells (EC) and tumor fibroblasts, can mimic the in vivo tumor microenvironment. Collectively, bioengineered tumors create an important resource for the in vitro study of tumor growth in 3D including tumor biomechanics and the effects of anti-cancer drugs on 3D tumor tissue. These technologies have the potential to overcome current limitations to genetic and histological tumor classification and development of personalized therapies.
650 0 $a Cancer research. $3 1253664
650 1 4 $a Cancer Research. $3 668358
700 1 $a Soker, Shay. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1287809
700 1 $a Skardal, Aleksander. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1287810
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319605098
776 0 8 $i Printed edition: $z 9783319605104
776 0 8 $i Printed edition: $z 9783319868745
830 0 $a Cancer Drug Discovery and Development, $x 2196-9906 $3 1253870
856 4 0 $u https://doi.org/10.1007/978-3-319-60511-1
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)